or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    ALGS F Aligos Therapeutics, Inc. -0.18
    ALNY C Alnylam Pharmaceuticals, Inc. -0.76
    TARA D ArTara Therapeutics, Inc. 4.36
    BLTE C Belite Bio, Inc. 0.64
    BFRG F Bullfrog AI Holdings, Inc 6.02
    GNFT B GENFIT S.A. 1.20
    GRI F GRI Bio, Inc. -4.88
    GALT C Galectin Therapeutics Inc. -0.63
    GILD F Gilead Sciences, Inc. -1.02
    GYRE D Gyre Therapeutics, Inc. -9.56
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Medicine Biopharmaceutical Alcohol Clinical Medicine Coronavirus Drug Development Fatty Liver Disease Hepatology Liver Fibrosis Pulmonary Arterial Hypertension Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Deficiency Amyloid Amyloidosis Angina Antibiotics

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    IBB C iShares Nasdaq Biotechnology Index Fund 9.51
    IBBQ B Invesco Nasdaq Biotechnology ETF 9.4
    BBH B Market Vectors Biotech ETF 9.28
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.01
    GERM B ETFMG Treatments Testing and Advancements ETF 6.84
    View all Liver Disease ETFs...
    Compare ETFs
    Compare IBB to GERM Compare IBB to IBBQ Compare IBBQ to BBH

        Liver Disease Stocks Recent News

        Date Stock Title
        May 21 TARA Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
        May 20 GILD Gilead touts additional data on liver disease asset seladelpar ahead of PDUFA date
        May 20 GILD Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch
        May 20 GRI GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
        May 19 GILD Biopharma M&A surges year over year in Q1
        May 18 GILD Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
        May 16 ALGS After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)
        May 16 BFRG BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
        May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
        May 15 GALT Galectin Therapeutics GAAP EPS of -$0.19
        May 15 GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
        May 15 BLTE Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
        May 15 BLTE Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
        May 14 BLTE Belite Bio reports Q1 results
        May 14 GILD Gilead Sciences, Inc. (GILD) BofA Securities 2024 Health Care Conference (Transcript)
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Medicine Biopharmaceutical Alcohol Clinical Medicine Coronavirus Drug Development Fatty Liver Disease Hepatology Liver Fibrosis Pulmonary Arterial Hypertension Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Deficiency Amyloid Amyloidosis Angina Antibiotics
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags